Publicaciones (54) Publicaciones en las que ha participado algún/a investigador/a

2013

  1. 18F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: A prospective validation of long-term outcomes

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 5, pp. 657-667

  2. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

    Journal of Hepatology, Vol. 59, Núm. 1, pp. 81-88

  3. A novel BRCA1 mutation in a patient with breast and ovarian cancer: A case report

    Oncology Letters, Vol. 6, Núm. 3, pp. 725-727

  4. Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert review

    Critical Reviews in Oncology/Hematology, Vol. 85, Núm. 2, pp. 149-161

  5. Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study

    Thrombosis Research, Vol. 132, Núm. 6, pp. 666-670

  6. Agonist antibodies to TNFR molecules that costimulate T and NK cells

    Clinical Cancer Research, Vol. 19, Núm. 5, pp. 1044-1053

  7. Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein

    Cancer Research, Vol. 73, Núm. 1, pp. 139-149

  8. Bevacizumab as front-line treatment for newly diagnosed epithelial cancer

    Expert Review of Anticancer Therapy, Vol. 13, Núm. 2, pp. 123-129

  9. Chemoradiation for resected pancreatic adenocarcinoma with or without intraoperative radiation therapy boost: Long-term outcomes

    Pancreatology, Vol. 13, Núm. 6, pp. 576-582

  10. Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination

    Clinical Cancer Research, Vol. 19, Núm. 5, pp. 997-1008

  11. Clinical management of small-cell carcinoma of the urinary tract: A 10-year single-center's experience

    Clinical Genitourinary Cancer, Vol. 11, Núm. 2, pp. 168-174

  12. Clinical significance of VEGFR-2 and 18F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 11, pp. 1635-1644

  13. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model

    Clinical Cancer Research, Vol. 19, Núm. 22, pp. 6151-6162

  14. Current treatment of rectal cancer adapted to the individual patient

    Reports of Practical Oncology and Radiotherapy, Vol. 18, Núm. 6, pp. 353-362

  15. Células dendríticas especializadas en presentación de antígenos exógenos a linfocitos T citotóxicos

    Anales del sistema sanitario de Navarra, Vol. 36, Núm. 3, pp. 519-537

  16. Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer

    European Journal of Cancer, Vol. 49, Núm. 18, pp. 3831-3838

  17. Feasibility of integrating a multi-camera optical tracking system in intra-operative electron radiation therapy scenarios

    Physics in Medicine and Biology, Vol. 58, Núm. 24, pp. 8769-8782

  18. GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012

    Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 509-525

  19. How to become a professor?

    Reports of Practical Oncology and Radiotherapy, Vol. 18, pp. S33

  20. Hypomagnesemia as a possible explanation behind episodes of severe pain in cancer patients receiving palliative care

    Supportive Care in Cancer, Vol. 21, Núm. 2, pp. 649-652